|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | VX-950,a novel hepatitis C virus (HCV) NS3-4A protease inhibitor,exhibits potent antiviral activities in HCV replicon cells显示文摘 | Lin K Perni RB Kwong AD | 2006 | Antimicrob Agents Chemother2006，50，5： | 1 |
| 2 | Preclinical profile of VX-950,a potent,selective,and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease显示文摘 | Perni RB Almquist SJ Byrn RA | 2006 | Antimicrob Agents Chemother2006，50，3： | 1 |
| 3 | Preclinical profile of VX - 950, a potent, selective, and orally bioavailable inhibithor of hepatitis C vires NS3 -4A serine protease 显示文摘 | Perni RB Almquist SJ Byrn RA | 2006 | Antimlcrob Agents Chemother2006，50，3： | 1 |
| 4 | Clinical significance of first trimester crown-rump length dispartity in dichorionic twingestations显示文摘 | Kalish RB Gupta M Perni SC | 2004 | Am J Obstet Gyneeol2004，191，14： | 1 |
| 5 | Preclinical profile ofVX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C vires NS3-4A serine protease 显示文摘 | Perni RB Almquist S J Byrn RA | 2006 | Antimicrob Agents Chemother2006，50，3： | 1 |
| 6 | Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3/4A serine protease 显示文摘 | Lin C Kwong AD Perni RB | 2006 | Infect Disord Drug Targets2006，6，1： | 1 |
| 7 | Preclinical pro- file of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3 -4A serine protease 显示文摘 | PERNI RB ALMQUIST S J BYRN RA | 2006 | Antimicrob Agents Chemother2006，50，3： | 1 |
| 8 | Preclinical profile of VX-950,a potent,selective,and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease显示文摘 | Perni RB Almquist SJ Byrn RA | 2006 | Antimicrob Agents Chemother2006，50，3： | 1 |
| 9 | Preclinical profile of VX- 950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease显示文摘 | Perni RB Almquist SJ Byrn RA | 2006 | Antimierob Agents Chemother2006，50，： | 1 |
| 10 | Differential expression of immune system-related components in midtrimester amniotic fluid from singleton and twin pregnancies显示文摘 | Perni SC Kalish RB Hutson JM | 2005 | Am J Obstet Gyne- col2005，193，32： | 1 |
| 11 | Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic显示文摘 | Thomson JA Perni RB | 2006 | Curr Opin Drug Discov Devel2006，9，5： | 1 |
| 12 | Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication显示文摘 | PERNI RB CONWAY SC LADNER SK | 2000 | Bioorg Med Chem Lett2000，10，23： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员